16 patents
Utility
Pyrrolobenzodiazepine-antibody conjugates
14 Nov 23
Patricius Hendrikus Cornelis Van Berkel
Filed: 24 Sep 21
Utility
Pyrrolobenzodiazepine-antibody conjugates
10 Oct 23
Conjugates of an antibody that binds to CD25 with PBD dimers.
Patricius Hendrikus Cornelis Van Berkel, Philip Wilson Howard
Filed: 19 Aug 20
Utility
Site-specific antibody-drug conjugates
18 Jul 23
Site-specific antibody-drug conjugates are described, in particular conjugates comprising pyrrolobenzodiazepines (PBDs) having a labile protecting group in the form of a linker.
Patricius Hendrikus Cornelis Van Berkel, Philip Wilson Howard
Filed: 14 Nov 19
Utility
Pyrrolobenzodiazepine-anti-CD22 antibody conjugates
4 Jul 23
The disclosure provides conjugates of an isolated humanized anti-CD22 antibody and PBD dimers.
Patricius Hendrikus Cornelis Van Berkel, Philip Wilson Howard
Filed: 26 May 20
Utility
Combination therapy with an anti-CD25 antibody-drug conjugate
7 Mar 23
The present disclosure relates to combination therapies for the treatment of pathological conditions, such as cancer.
Patricius Hendrikus Cornelis Van Berkel, Lisa Skelton, Francesca Zammarchi, Jay Marshall Feingold, Jens Wuerthner, John Hartley
Filed: 20 Apr 18
Utility
Pyrrolobenzodiazepine-antibody conjugates
1 Nov 22
The present disclosure relates to pyrrolobenzodiazepines (PBDs) having a labile C2 or N10 protecting group in the form of a linker to an antibody.
Patricius Hendrikus Cornelis Van Berkel
Filed: 20 Jul 21
Utility
Dosage regimes for the administration of an anti-CD25 ADC
30 Aug 22
Jay Marshall Feingold, Jens Wuerthner
Filed: 14 Jun 18
Utility
Pyrrolobenzodiazepine-antibody conjugates
12 Jul 22
The present invention relates to pyrrolobenzodiazepines (PBDs) having a labile protecting group in the form of a linker to an antibody.
Patricius Hendrikus Cornelis Van Berkel
Filed: 8 Feb 18
Utility
Dosage regimes for the administration of an anti-CD19 ADC
3 May 22
The present disclosure relates to the treatment of pathological conditions, such as cancer, with Antibody Drug Conjugates (ADCs).
Jay Marshall Feingold, David Rodney Ungar
Filed: 14 Jun 18
Utility
Pyrrolobenzodiazepine-antibody conjugates
2 Nov 21
Patricius Hendrikus Cornelis Van Berkel
Filed: 8 Feb 18
Utility
Method for treating breast cancer
10 Aug 21
Breast cancer cells lacking ER protein expression, PgR protein expression and/or showing absence of HER2 protein over-expression (i.e., triple-negative breast cancer cells, basal-like) can be efficiently targeted with an anti-KAAG1 antibody and killed upon delivery of a therapeutic moiety.
Gilles Bernard Tremblay, Anna N. Moraitis, Mario Filion
Filed: 18 Oct 18
Utility
Pyrrolobenzodiazepine-antibody conjugates
12 Oct 20
Conjugates of an antibody that binds to CD25 with PBD dimers.
Patricius Hendrikus Cornelis Van Berkel, Philip Wilson Howard
Filed: 4 Mar 18
Utility
Pyrrolobenzodiazepine-antibody conjugates
21 Sep 20
The present disclosure relates to the use of antibody-drug conjugates (ADCs) comprising pyrrolobenzodiazepine (PBD) dimers and anti-CD25 antibodies for use in treating disorders characterized by the presence of CD25+ve cells.
Patricius Henrikus Cornelis Van Berkel, Philip Wilson Howard, John Hartley
Filed: 24 Nov 15
Utility
Pyrrolobenzodiazepine-anti-CD22 antibody conjugates
27 Jul 20
Conjugates of an isolated humanized, anti-CD22 antibody with PBD dimers.
Philip Wilson Howard, Patricius Hendrikus Cornelis Van Berkel
Filed: 30 Jan 18
Utility
Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
23 Mar 20
Novel antibodies and antigen binding fragments that specifically bind to KAAG1 and which may be used in the treatment, detection and diagnosis of cancer comprising KAAG1-expressing cells are disclosed herein.
Gilles Bernard Tremblay, Anna N. Moraitis, Traian Sulea, Mario Filion
Filed: 12 Nov 17
Utility
Combination therapy with an anti-axl antibody-drug conjugate
27 Jan 20
The present disclosure relates to combination therapies for the treatment of pathological conditions, such as cancer.
Patricius Hendrikus Cornelis Van Berkel, Jens Wuerthner, John Hartley, Francesca Zammarchi
Filed: 20 Nov 18
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first